Gadobutrol (CAS 138071-82-6) Market Report

China Gadobutrol (CAS 138071-82-6) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 31, 2023
  • PAGES：194
  • REPORT CODE：GMM1767407
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Gadobutrol (CAS 138071-82-6) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • SWAPNROOP DRUGS & PHARMACEUTICALS

    • Manus Aktteva Biopharma LLP

    • Advanced Technology & Industrail Co, Ltd

    • Jilin Tely Imp & Exp CO,LTD

    • BOC Sciences

    • LGM Pharma

    • MedKoo Biosciences, Inc

    • Bayer HealthCare Pharmaceuticals Inc

    By Type:

    • Single Dose Vials (2 mL, 75 mL, 10mL, and 15 mL)

    • Single Dose Pre-filled Injections (75 mL, 10 mL, 15 mL)

    • Pharmacy Bulk Packages (30 mL and 65 mL)

    By Application:

    • Children

    • Adults

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Gadobutrol (CAS 138071-82-6) Market Overview 2018-2029

    • 1.1 China Gadobutrol (CAS 138071-82-6) Industry Development Overview

    • 1.2 China Gadobutrol (CAS 138071-82-6) Industry Development History

    • 1.3 China Gadobutrol (CAS 138071-82-6) Industry Market Size (2018-2029)

    • 1.4 China Gadobutrol (CAS 138071-82-6) Market Analysis by Type from Production Side

      • 1.4.1 China Gadobutrol (CAS 138071-82-6) Production Volume, Production Value and Growth Rate of Single Dose Vials (2 mL, 75 mL, 10mL, and 15 mL) (2018-2029)

      • 1.4.2 China Gadobutrol (CAS 138071-82-6) Production Volume, Production Value and Growth Rate of Single Dose Pre-filled Injections (75 mL, 10 mL, 15 mL) (2018-2029)

      • 1.4.3 China Gadobutrol (CAS 138071-82-6) Production Volume, Production Value and Growth Rate of Pharmacy Bulk Packages (30 mL and 65 mL) (2018-2029)

    • 1.5 China Gadobutrol (CAS 138071-82-6) Market Analysis by Application from Consumption End

      • 1.5.1 China Gadobutrol (CAS 138071-82-6) Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

      • 1.5.2 China Gadobutrol (CAS 138071-82-6) Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)

    • 1.6 China Gadobutrol (CAS 138071-82-6) Market Analysis by Region

      • 1.6.1 North China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Gadobutrol (CAS 138071-82-6) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Gadobutrol (CAS 138071-82-6) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Gadobutrol (CAS 138071-82-6) Market Status and Competition Analysis in 2023

      • 2.2.3 China Gadobutrol (CAS 138071-82-6) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Gadobutrol (CAS 138071-82-6) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Gadobutrol (CAS 138071-82-6) Industry Development

    Chapter 3 Gadobutrol (CAS 138071-82-6)Industry Chain Analysis

    • 3.1 Gadobutrol (CAS 138071-82-6) Industry Chain

    • 3.2 Gadobutrol (CAS 138071-82-6) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Gadobutrol (CAS 138071-82-6) Market

    • 3.3 Gadobutrol (CAS 138071-82-6) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Gadobutrol (CAS 138071-82-6) Market

    Chapter 4 China Gadobutrol (CAS 138071-82-6) Market, by Type

    • 4.1 China Gadobutrol (CAS 138071-82-6) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Gadobutrol (CAS 138071-82-6) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Gadobutrol (CAS 138071-82-6) Production Volume and Growth Rate, by Type

      • 4.5.1 China Gadobutrol (CAS 138071-82-6) Production Volume and Growth Rate of Single Dose Vials (2 mL, 75 mL, 10mL, and 15 mL)

      • 4.5.2 China Gadobutrol (CAS 138071-82-6) Production Volume and Growth Rate of Single Dose Pre-filled Injections (75 mL, 10 mL, 15 mL)

      • 4.5.3 China Gadobutrol (CAS 138071-82-6) Production Volume and Growth Rate of Pharmacy Bulk Packages (30 mL and 65 mL)

    Chapter 5 China Gadobutrol (CAS 138071-82-6) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Gadobutrol (CAS 138071-82-6) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate, by Application

      • 5.5.1 China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate of Children

      • 5.5.2 China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate of Adults

    Chapter 6 China Gadobutrol (CAS 138071-82-6) Market, by Region

    • 6.1 China Gadobutrol (CAS 138071-82-6) Production Volume and Production Value, by Region

    • 6.2 China Gadobutrol (CAS 138071-82-6) Sales Volume and Sales Value, by Region

    Chapter 7 North China Gadobutrol (CAS 138071-82-6) Market Analysis

    • 7.1 North China Gadobutrol (CAS 138071-82-6) Market, by Type

    • 7.2 North China Gadobutrol (CAS 138071-82-6) Market, by Application

    Chapter 8 Central China Gadobutrol (CAS 138071-82-6) Market Analysis

    • 8.1 Central China Gadobutrol (CAS 138071-82-6) Market, by Type

    • 8.2 Central China Gadobutrol (CAS 138071-82-6) Market, by Application

    Chapter 9 South China Gadobutrol (CAS 138071-82-6) Market Analysis

    • 9.1 South China Gadobutrol (CAS 138071-82-6) Market, by Type

    • 9.2 South China Gadobutrol (CAS 138071-82-6) Market, by Application

    Chapter 10 East China Gadobutrol (CAS 138071-82-6) Market Analysis

    • 10.1 East China Gadobutrol (CAS 138071-82-6) Market, by Type

    • 10.2 East China Gadobutrol (CAS 138071-82-6) Market, by Application

    Chapter 11 Northeast China Gadobutrol (CAS 138071-82-6) Market Analysis

    • 11.1 Northeast China Gadobutrol (CAS 138071-82-6) Market, by Type

    • 11.2 Northeast China Gadobutrol (CAS 138071-82-6) Market, by Application

    Chapter 12 Southwest China Gadobutrol (CAS 138071-82-6) Market Analysis

    • 12.1 Southwest China Gadobutrol (CAS 138071-82-6) Market, by Type

    • 12.2 Southwest China Gadobutrol (CAS 138071-82-6) Market, by Application

    Chapter 13 Northwest China Gadobutrol (CAS 138071-82-6) Market Analysis

    • 13.1 Northwest China Gadobutrol (CAS 138071-82-6) Market, by Type

    • 13.2 Northwest China Gadobutrol (CAS 138071-82-6) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 SWAPNROOP DRUGS & PHARMACEUTICALS

        • 14.1.1 SWAPNROOP DRUGS & PHARMACEUTICALS Company Profile

        • 14.1.2 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Manus Aktteva Biopharma LLP

        • 14.2.1 Manus Aktteva Biopharma LLP Company Profile

        • 14.2.2 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Advanced Technology & Industrail Co, Ltd

        • 14.3.1 Advanced Technology & Industrail Co, Ltd Company Profile

        • 14.3.2 Advanced Technology & Industrail Co, Ltd Gadobutrol (CAS 138071-82-6) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Jilin Tely Imp & Exp CO,LTD

        • 14.4.1 Jilin Tely Imp & Exp CO,LTD Company Profile

        • 14.4.2 Jilin Tely Imp & Exp CO,LTD Gadobutrol (CAS 138071-82-6) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 BOC Sciences

        • 14.5.1 BOC Sciences Company Profile

        • 14.5.2 BOC Sciences Gadobutrol (CAS 138071-82-6) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 LGM Pharma

        • 14.6.1 LGM Pharma Company Profile

        • 14.6.2 LGM Pharma Gadobutrol (CAS 138071-82-6) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 MedKoo Biosciences, Inc

        • 14.7.1 MedKoo Biosciences, Inc Company Profile

        • 14.7.2 MedKoo Biosciences, Inc Gadobutrol (CAS 138071-82-6) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bayer HealthCare Pharmaceuticals Inc

        • 14.8.1 Bayer HealthCare Pharmaceuticals Inc Company Profile

        • 14.8.2 Bayer HealthCare Pharmaceuticals Inc Gadobutrol (CAS 138071-82-6) Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Gadobutrol (CAS 138071-82-6) Industry Research Conclusions

    • 15.2 Gadobutrol (CAS 138071-82-6) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Gadobutrol (CAS 138071-82-6) Industry Market Size (2018-2029)

    • Figure China Gadobutrol (CAS 138071-82-6) Production Volume, Production Value and Growth Rate of Single Dose Vials (2 mL, 75 mL, 10mL, and 15 mL) (2018-2029)

    • Figure China Gadobutrol (CAS 138071-82-6) Production Volume, Production Value and Growth Rate of Single Dose Pre-filled Injections (75 mL, 10 mL, 15 mL) (2018-2029)

    • Figure China Gadobutrol (CAS 138071-82-6) Production Volume, Production Value and Growth Rate of Pharmacy Bulk Packages (30 mL and 65 mL) (2018-2029)

    • Figure China Gadobutrol (CAS 138071-82-6) Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

    • Figure China Gadobutrol (CAS 138071-82-6) Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)

    • Figure North China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

    • Figure Central China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

    • Figure South China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

    • Figure East China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate from 2018-2029

    • Figure Gadobutrol (CAS 138071-82-6) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Gadobutrol (CAS 138071-82-6) Market Share by Type in 2018

    • Figure China Gadobutrol (CAS 138071-82-6) Market Share by Type in 2023

    • Figure China Gadobutrol (CAS 138071-82-6) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Gadobutrol (CAS 138071-82-6) Production Volume and Growth Rate of Single Dose Vials (2 mL, 75 mL, 10mL, and 15 mL) (2018-2023)

    • Figure China Gadobutrol (CAS 138071-82-6) Production Volume and Growth Rate of Single Dose Pre-filled Injections (75 mL, 10 mL, 15 mL) (2018-2023)

    • Figure China Gadobutrol (CAS 138071-82-6) Production Volume and Growth Rate of Pharmacy Bulk Packages (30 mL and 65 mL) (2018-2023)

    • Figure China Gadobutrol (CAS 138071-82-6) Market Share by Application in 2018

    • Figure China Gadobutrol (CAS 138071-82-6) Market Share by Application in 2023

    • Figure China Gadobutrol (CAS 138071-82-6) Total Market Size and Growth Rate from Consumption End

    • Figure China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate of Children (2018-2023)

    • Figure China Gadobutrol (CAS 138071-82-6) Market Size and Growth Rate of Adults (2018-2023)

    • Table China Gadobutrol (CAS 138071-82-6) Production Volume by Region (2018-2023)

    • Table China Gadobutrol (CAS 138071-82-6) Production Volume Share by Region (2018-2023)

    • Figure China Gadobutrol (CAS 138071-82-6) Production Volume Share by Region (2018-2023)

    • Table China Gadobutrol (CAS 138071-82-6) Production Value by Region (2018-2023)

    • Table China Gadobutrol (CAS 138071-82-6) Production Value Share by Region (2018-2023)

    • Figure China Gadobutrol (CAS 138071-82-6) Production Value Share by Region (2018-2023)

    • Table China Gadobutrol (CAS 138071-82-6) Sales Volume by Region (2018-2023)

    • Table China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Region (2018-2023)

    • Figure China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Region (2018-2023)

    • Table China Gadobutrol (CAS 138071-82-6) Sales Value by Region (2018-2023)

    • Table China Gadobutrol (CAS 138071-82-6) Sales Value Share by Region (2018-2023)

    • Figure China Gadobutrol (CAS 138071-82-6) Sales Value Share by Region (2018-2023)

    • Table North China Gadobutrol (CAS 138071-82-6) Production Volume by Type (2018-2023)

    • Table North China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Figure North China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Table North China Gadobutrol (CAS 138071-82-6) Sales Volume by Application (2018-2023)

    • Table North China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Figure North China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Table Central China Gadobutrol (CAS 138071-82-6) Production Volume by Type (2018-2023)

    • Table Central China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Figure Central China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Table Central China Gadobutrol (CAS 138071-82-6) Sales Volume by Application (2018-2023)

    • Table Central China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Figure Central China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Table South China Gadobutrol (CAS 138071-82-6) Production Volume by Type (2018-2023)

    • Table South China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Figure South China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Table South China Gadobutrol (CAS 138071-82-6) Sales Volume by Application (2018-2023)

    • Table South China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Figure South China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Table East China Gadobutrol (CAS 138071-82-6) Production Volume by Type (2018-2023)

    • Table East China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Figure East China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Table East China Gadobutrol (CAS 138071-82-6) Sales Volume by Application (2018-2023)

    • Table East China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Figure East China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Gadobutrol (CAS 138071-82-6) Production Volume by Type (2018-2023)

    • Table Northeast China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Table Northeast China Gadobutrol (CAS 138071-82-6) Sales Volume by Application (2018-2023)

    • Table Northeast China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Gadobutrol (CAS 138071-82-6) Production Volume by Type (2018-2023)

    • Table Southwest China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Table Southwest China Gadobutrol (CAS 138071-82-6) Sales Volume by Application (2018-2023)

    • Table Southwest China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Gadobutrol (CAS 138071-82-6) Production Volume by Type (2018-2023)

    • Table Northwest China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Gadobutrol (CAS 138071-82-6) Production Volume Share by Type (2018-2023)

    • Table Northwest China Gadobutrol (CAS 138071-82-6) Sales Volume by Application (2018-2023)

    • Table Northwest China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Gadobutrol (CAS 138071-82-6) Sales Volume Share by Application (2018-2023)

    • Table SWAPNROOP DRUGS & PHARMACEUTICALS Company Profile

    • Table SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Revenue, Price and Gross (2018-2023)

    • Table Manus Aktteva Biopharma LLP Company Profile

    • Table Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Revenue, Price and Gross (2018-2023)

    • Table Advanced Technology & Industrail Co, Ltd Company Profile

    • Table Advanced Technology & Industrail Co, Ltd Gadobutrol (CAS 138071-82-6) Revenue, Price and Gross (2018-2023)

    • Table Jilin Tely Imp & Exp CO,LTD Company Profile

    • Table Jilin Tely Imp & Exp CO,LTD Gadobutrol (CAS 138071-82-6) Revenue, Price and Gross (2018-2023)

    • Table BOC Sciences Company Profile

    • Table BOC Sciences Gadobutrol (CAS 138071-82-6) Revenue, Price and Gross (2018-2023)

    • Table LGM Pharma Company Profile

    • Table LGM Pharma Gadobutrol (CAS 138071-82-6) Revenue, Price and Gross (2018-2023)

    • Table MedKoo Biosciences, Inc Company Profile

    • Table MedKoo Biosciences, Inc Gadobutrol (CAS 138071-82-6) Revenue, Price and Gross (2018-2023)

    • Table Bayer HealthCare Pharmaceuticals Inc Company Profile

    • Table Bayer HealthCare Pharmaceuticals Inc Gadobutrol (CAS 138071-82-6) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US